Unresectable, locally advanced, metastatic ccRCC with progression following prior anti-PD-1, PD-L1 with no prior exposure to HIF-2αinhibitors or cabozantinib. The gene discussed is PDCD1; the disease is nonpapillary renal cell carcinoma.